Colgate-Palmolive Co.sees Pfizer Inc.’s Listerine mouthwash as something that could fit very well in its oral care product lineup, and would look at other parts of Pfizer’s business up for sale but would not overpay, Colgate’s president said. President and chief operating officer Ian Cook told investors at a Bank of America conference that Listerine is strategically right and that Colgate will look at buying the brand “very, very aggressively.” Pfizer said in Febr...